Cross Andrew, Mahmoud Mahmoud, Ozdag Yagiz, Koshinski Jessica L, Garcia Victoria C, Dwyer C Liam, Klena Joel C, Grandizio Louis C
Department of Orthopaedic Surgery, Geisinger Musculoskeletal Institute, Geisinger Commonwealth School of Medicine, Danville, PA.
J Hand Surg Glob Online. 2024 Dec 17;7(2):167-172. doi: 10.1016/j.jhsg.2024.11.010. eCollection 2025 Mar.
The Drug Enforcement Agency has categorized marijuana as a schedule 1 substance. In states where marijuana is legal, health care systems and licensing boards restrict usage by health care professionals outside of work, unlike alcohol. Considering the paucity of evidence with respect to clinical efficacy and the legal ambiguity associated with marijuana, the purpose of this investigation was to quantify patient perceptions of marijuana use. We sought to evaluate patient perceptions of potential marijuana use by physicians, compared with other substances such as alcohol and nicotine.
Four hundred thirteen anonymous, 19-question surveys were administered to upper-extremity patients at a single institution. Surveys included demographics, the Brief Marijuana Effect Expectancies Questionnaire, and questions analyzing willingness to discuss/use marijuana as part of treatment. Patients were asked to answer the following using a five-point Likert scale: "." A binary logistic regression model was constructed to assess the significance of patient demographics associated with perceptions of physician marijuana usage.
A total of 388 (94%) surveys were included. Forty percent of respondents had used marijuana. Forty percent were open to using marijuana as part of a treatment plan. Sixty-four percent agreed that they were comfortable with their doctor using alcohol outside of work compared with 47% for recreational marijuana. Demographic factors and personal history of marijuana use were not associated with perceptions of potential physician use.
Patient perceptions of marijuana use are variable. More patients were comfortable with their physician using marijuana outside of work than not. Patients were as comfortable with their physicians using medical marijuana as they were with nicotine.
As federal and state laws surrounding marijuana use change, understanding patient perceptions of potential physician use may play a role in determining health system and licensing board policies.
美国缉毒局已将大麻归类为一类管制物质。在大麻合法的州,医疗保健系统和许可委员会会限制医疗保健专业人员在工作之外使用大麻,这与酒精不同。鉴于关于大麻临床疗效的证据匮乏以及与大麻相关的法律模糊性,本调查的目的是量化患者对使用大麻的看法。我们试图评估患者对医生使用大麻可能性的看法,并与酒精和尼古丁等其他物质进行比较。
在一家机构对413名上肢患者进行了19个问题的匿名调查。调查内容包括人口统计学信息、简短大麻效应预期问卷,以及分析作为治疗一部分讨论/使用大麻意愿的问题。要求患者使用五点李克特量表回答以下问题:“……”构建二元逻辑回归模型以评估与患者对医生使用大麻看法相关的人口统计学因素的显著性。
共纳入388份(94%)调查问卷。40%的受访者使用过大麻。40%的人愿意将大麻作为治疗计划的一部分使用。64%的人同意他们对医生在工作之外饮酒感到放心,相比之下,对医生在工作之外使用娱乐性大麻感到放心的比例为47%。人口统计学因素和个人大麻使用史与对医生可能使用大麻的看法无关。
患者对使用大麻的看法各不相同。更多患者对医生在工作之外使用大麻感到放心,而非不放心。患者对医生使用医用大麻和使用尼古丁一样放心。
随着围绕大麻使用的联邦和州法律不断变化,了解患者对医生可能使用大麻的看法可能在确定卫生系统和许可委员会政策方面发挥作用。